.png){kind=logo}
Gaudium IVF & Women Health shares debuted at a premium on listing day but erased early gains as broader market weakness weighed on sentiment. The initial public offer (IPO) of Gaudium IVF and Women Health was subscribed 7.27 times. The issue opened for bidding on 20 February 2026 and it closed on 24 February 2026.
Gaudium IVF and Women Health shares debuted at a modest premium on the BSE and the NSE on Friday, February 27. The stock failed to hold gains amid weak stock market sentiment.
The Rs. 165 crore IPO shares opened at Rs. 83 on the BSE, up 5% from its issue price of Rs. 79. However, it erased gains to hit the day's low of Rs. 79.05. On the NSE, Gaudium IVF's share price debuted at Rs. 83 and erased gains, dropping to Rs. 80.
Around 10:30 am, the stock was trading at Rs. 80.75 on the BSE and at Rs. 80.50 on the NSE.
The initial public offering was booked 7.27 times, as it mobilised bids for 10,63,50,489 equity shares against 1,46,20,340 shares on offer, according to the consolidated data on the NSE website.
Prior to the IPO, the firm secured Rs. 49.5 crore in the anchor round from investors including MERU Investment Fund PCC-CELL, Carnelian India Multi Strategy Fund, Sanshi Fund I and Hornbill Orchid India Fund. The company allocated 62,65,860 shares to these investors at Rs. 79 apiece.
The portion reserved for qualified institutional buyers (QIBs) received a subscription of 1.62 times the amount. Priced at Rs. 79 per share, the issue was a combination of a fresh issue of 1,13,92,500 shares for Rs. 90 crore and an offer for sale (OFS) of 94,93,700 shares for Rs. 75 crore.
Sarthi Capital Advisors Private Limited was the book-running lead manager, while Bigshare Services Private Limited was the registrar of the issue.
Founded by Khanna, Gaudium IVF offers IVF treatments in India. It operates through a hub-and-spoke model, with seven hubs and 28 spokes across multiple states.
Its main centers (hubs) are located in major cities of which two centers are located in Delhi (Janakpuri and Kailash Colony), one center in Maharashtra (Mumbai - Khar West), one center in Punjab (Ludhiana), one center in Jammu & Kashmir (Srinagar), one center in Bihar (Patna) and one center in Karnataka (Bangalore), to cater potential locations across India.
On the financial front, the company recorded revenue from operations of Rs. 70.72 crore and a profit after tax of Rs. 19.13 crore for the financial year 2024-25. In FY24, revenue and profit stood at Rs. 47.89 crore and Rs. 10.31 crore, respectively.
Also Read: Stock Market Today: Sensex Falls 520 Points, Nifty at 25,308; Infosys Shares Jump 2.41%
The listing was slightly better than what the grey markets were expecting. According to grey market sources, the last grey market premium (GMP) of Gaudium IVF was nil, which suggested the stock could have listed at par with the issue price.
The Indian stock market witnessed strong selling in the morning session on Friday. The Sensex declined over 550 points, while the Nifty 50 slipped below 25,300, falling 0.80% in the morning session.
